IL145952A0 - Polymorphs of crystalline (2-benzhydryl-1-azabicyclo [2.2.2.] oct-3-yl) - (5-iso-propyl-2-methoxybenzyl) - amine citrate as nk-1 receptor antagonists - Google Patents
Polymorphs of crystalline (2-benzhydryl-1-azabicyclo [2.2.2.] oct-3-yl) - (5-iso-propyl-2-methoxybenzyl) - amine citrate as nk-1 receptor antagonistsInfo
- Publication number
- IL145952A0 IL145952A0 IL14595200A IL14595200A IL145952A0 IL 145952 A0 IL145952 A0 IL 145952A0 IL 14595200 A IL14595200 A IL 14595200A IL 14595200 A IL14595200 A IL 14595200A IL 145952 A0 IL145952 A0 IL 145952A0
- Authority
- IL
- Israel
- Prior art keywords
- benzhydryl
- azabicyclo
- polymorphs
- methoxybenzyl
- iso
- Prior art date
Links
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 title 1
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 title 1
- -1 oct-3-yl Chemical group 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13699599P | 1999-06-01 | 1999-06-01 | |
PCT/IB2000/000663 WO2000073303A1 (en) | 1999-06-01 | 2000-05-17 | Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145952A0 true IL145952A0 (en) | 2002-07-25 |
Family
ID=22475353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14595200A IL145952A0 (en) | 1999-06-01 | 2000-05-17 | Polymorphs of crystalline (2-benzhydryl-1-azabicyclo [2.2.2.] oct-3-yl) - (5-iso-propyl-2-methoxybenzyl) - amine citrate as nk-1 receptor antagonists |
Country Status (38)
Country | Link |
---|---|
US (1) | US6387925B1 (zh) |
EP (1) | EP1181289A1 (zh) |
JP (1) | JP2003501353A (zh) |
KR (1) | KR20020005055A (zh) |
CN (1) | CN1353712A (zh) |
AP (1) | AP2001002350A0 (zh) |
AR (1) | AR029753A1 (zh) |
AU (1) | AU767331B2 (zh) |
BG (1) | BG106139A (zh) |
BR (1) | BR0011125A (zh) |
CA (1) | CA2372236A1 (zh) |
CO (1) | CO5170468A1 (zh) |
CR (1) | CR6513A (zh) |
CZ (1) | CZ20014270A3 (zh) |
DZ (1) | DZ3051A1 (zh) |
EA (1) | EA004206B1 (zh) |
EE (1) | EE200100655A (zh) |
GT (1) | GT200000086A (zh) |
HK (1) | HK1046407A1 (zh) |
HN (1) | HN2000000076A (zh) |
HR (1) | HRP20010884A2 (zh) |
HU (1) | HUP0201798A3 (zh) |
IL (1) | IL145952A0 (zh) |
IS (1) | IS6129A (zh) |
MX (1) | MXPA01012328A (zh) |
NO (1) | NO20015845L (zh) |
NZ (1) | NZ514762A (zh) |
OA (1) | OA11955A (zh) |
PA (1) | PA8496001A1 (zh) |
PE (1) | PE20010155A1 (zh) |
PL (1) | PL352715A1 (zh) |
SK (1) | SK17342001A3 (zh) |
SV (1) | SV2002000092A (zh) |
TN (1) | TNSN00119A1 (zh) |
TR (1) | TR200103472T2 (zh) |
UY (1) | UY26177A1 (zh) |
WO (1) | WO2000073303A1 (zh) |
ZA (1) | ZA200109839B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002334103A1 (en) * | 2002-10-04 | 2004-04-23 | Merck Sharp And Dohme Limited | Azabicyclic spiroether derivatives as receptor antagonists |
CA2610635A1 (en) * | 2003-06-18 | 2004-12-29 | Teva Pharmaceutical Industries Ltd | Fluvastatin sodium crystal form lxxxvii, processes for preparing, compositions and methods of using |
US7371906B2 (en) | 2004-08-24 | 2008-05-13 | Eastman Kodak Company | Process for photo-oxidative stability improvements |
US9446029B2 (en) | 2010-07-27 | 2016-09-20 | Colorado State University Research Foundation | Use of NK-1 receptor antagonists in management of visceral pain |
CN110577522B (zh) * | 2018-06-07 | 2022-12-27 | 东莞市东阳光动物保健药品有限公司 | 马罗匹坦柠檬酸盐新晶型及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
HU217548B (hu) * | 1991-05-31 | 2000-02-28 | Pfizer Inc. | Kinuklidinszármazékok és ilyen származékokat tartalmazó gyógyászati készítmények |
DE69307340T2 (de) * | 1992-11-12 | 1997-04-24 | Pfizer | Chinuclidin derivat als substanz p antagonist |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
US6262067B1 (en) * | 1999-06-22 | 2001-07-17 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
-
2000
- 2000-05-12 US US09/887,682 patent/US6387925B1/en not_active Expired - Fee Related
- 2000-05-17 CA CA002372236A patent/CA2372236A1/en not_active Abandoned
- 2000-05-17 CZ CZ20014270A patent/CZ20014270A3/cs unknown
- 2000-05-17 CN CN00808340A patent/CN1353712A/zh active Pending
- 2000-05-17 BR BR0011125-2A patent/BR0011125A/pt not_active IP Right Cessation
- 2000-05-17 JP JP2001500628A patent/JP2003501353A/ja active Pending
- 2000-05-17 OA OA1200100317A patent/OA11955A/en unknown
- 2000-05-17 HN HN2000000076A patent/HN2000000076A/es unknown
- 2000-05-17 IL IL14595200A patent/IL145952A0/xx unknown
- 2000-05-17 MX MXPA01012328A patent/MXPA01012328A/es not_active Application Discontinuation
- 2000-05-17 HU HU0201798A patent/HUP0201798A3/hu unknown
- 2000-05-17 WO PCT/IB2000/000663 patent/WO2000073303A1/en not_active Application Discontinuation
- 2000-05-17 NZ NZ514762A patent/NZ514762A/xx unknown
- 2000-05-17 EP EP00925526A patent/EP1181289A1/en not_active Withdrawn
- 2000-05-17 EA EA200100982A patent/EA004206B1/ru not_active IP Right Cessation
- 2000-05-17 AP APAP/P/2001/002350A patent/AP2001002350A0/en unknown
- 2000-05-17 KR KR1020017015324A patent/KR20020005055A/ko not_active Application Discontinuation
- 2000-05-17 EE EEP200100655A patent/EE200100655A/xx unknown
- 2000-05-17 SK SK1734-2001A patent/SK17342001A3/sk unknown
- 2000-05-17 TR TR2001/03472T patent/TR200103472T2/xx unknown
- 2000-05-17 AU AU44246/00A patent/AU767331B2/en not_active Ceased
- 2000-05-17 PL PL00352715A patent/PL352715A1/xx not_active Application Discontinuation
- 2000-05-19 PA PA20008496001A patent/PA8496001A1/es unknown
- 2000-05-26 CO CO00039192A patent/CO5170468A1/es not_active Application Discontinuation
- 2000-05-29 UY UY26177A patent/UY26177A1/es not_active Application Discontinuation
- 2000-05-30 GT GT200000086A patent/GT200000086A/es unknown
- 2000-05-30 AR ARP000102664A patent/AR029753A1/es unknown
- 2000-05-30 PE PE2000000517A patent/PE20010155A1/es not_active Application Discontinuation
- 2000-05-31 DZ DZ000102A patent/DZ3051A1/xx active
- 2000-05-31 SV SV2000000092A patent/SV2002000092A/es unknown
- 2000-05-31 TN TNTNSN00119A patent/TNSN00119A1/fr unknown
-
2001
- 2001-10-26 IS IS6129A patent/IS6129A/is unknown
- 2001-11-23 BG BG106139A patent/BG106139A/bg unknown
- 2001-11-27 CR CR6513A patent/CR6513A/es not_active Application Discontinuation
- 2001-11-27 HR HR20010884A patent/HRP20010884A2/hr not_active Application Discontinuation
- 2001-11-29 ZA ZA200109839A patent/ZA200109839B/xx unknown
- 2001-11-30 NO NO20015845A patent/NO20015845L/no not_active Application Discontinuation
-
2002
- 2002-10-30 HK HK02107840.5A patent/HK1046407A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6751301A (en) | 1,3,8-triaza-spiro'4,5]decan-4-one derivatives as neurokinin receptor antagonists | |
MXPA03009644A (es) | Grupos azabiciclicos sustituidos para el tratamiento de enfermedades. | |
PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
IL147977A0 (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain | |
HUP0202034A3 (en) | Heterocyclic substituted aminoazacycles useful as central nervous system agents | |
IL137936A0 (en) | 2-arylethyl- (piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists | |
IL146410A0 (en) | Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2] oct-3-yl)-(1so-propyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists | |
IL145952A0 (en) | Polymorphs of crystalline (2-benzhydryl-1-azabicyclo [2.2.2.] oct-3-yl) - (5-iso-propyl-2-methoxybenzyl) - amine citrate as nk-1 receptor antagonists | |
PL351088A1 (en) | Process for the preparation of substituted pyrimidines | |
HUP0102710A2 (hu) | Új eljárás prosztaglandinvegyületek előállítására | |
HK1039334A1 (en) | Process for preparing tricyclic compounds having antihistaminic activity | |
IL123740A0 (en) | NK-1 receptor antagonists for the treatment of delayed emesis | |
IL135809A0 (en) | Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein | |
TW441337U (en) | Improved structure of shaking machine for drinks | |
AU7025800A (en) | Process for the preparation of 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine | |
TW503847U (en) | Improved retainer structure for casters of machine | |
GB9906120D0 (en) | Process for the preparation of new heterocyclic compounds | |
AU7542900A (en) | Process for the preparation of paroxetine intermediate | |
SI1200414T1 (en) | Process for the preparation of substituted pyrimidines | |
GB9814737D0 (en) | Fibrinogen receptor antagonists |